These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9783402)

  • 1. [An antigenic analysis and the protective properties of the R-form lipopolysaccharides of gram-negative bacteria].
    Stanislavskiĭ ES; Makarenko TA; Kholodkova EV; Lugowski C
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):52-6. PubMed ID: 9783402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R-form lipopolysaccharides (LPS) of Gram-negative bacteria as possible vaccine antigens.
    Stanislavsky ES; Makarenko TA; Kholodkova EV; Lugowski C
    FEMS Immunol Med Microbiol; 1997 Jul; 18(3):139-45. PubMed ID: 9271164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
    Tyler JW; Spears H; Nelson R
    J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protection against experimental Salmonella typhimurium infection in mice. Immunostimulating activity of heterologous Salmonella S-forms, R-mutants, lipopolysaccharides and muramyl dipeptide in vaccines combined with S. typhimurium].
    Schlecht S
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):414-25. PubMed ID: 6385567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reaction between the genus-specific lipopolysaccharide antigen of Chlamydia spp. and the lipopolysaccharides of Porphyromonas gingivalis, Escherichia coli O119 and Salmonella newington: implications for diagnosis.
    Haralambieva I; Iankov I; Petrov D; Ivanova R; Kamarinchev B; Mitov I
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):99-106. PubMed ID: 11750161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse protection induced by Pseudomonas aeruginosa PAC1R and its defective mutants, Salmonella minnesota Re-mutant and Escherichia coli O14.
    Stanislavsky ES; Kholodkova EV; Makarenko TA; Sukhachevskaya MV
    FEMS Immunol Med Microbiol; 1995 Apr; 11(2):81-6. PubMed ID: 7640675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
    Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
    J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.
    Warren HS; Novitsky TJ; Bucklin A; Kania SA; Siber GR
    Infect Immun; 1987 Jul; 55(7):1668-73. PubMed ID: 3298063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The antigenic and immunogenic properties of the bivalent strain Shigella flexneri-Shigella sonnei 1 No. 200].
    Bondarenko VM; Nikolaeva AI; Marakusha BI; Belova TS
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):47-8. PubMed ID: 8553752
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
    Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
    J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divalent flagellin immunotherapy provides homologous and heterologous protection in experimental urinary tract infections in mice.
    Sabharwal N; Chhibber S; Harjai K
    Int J Med Microbiol; 2016 Jan; 306(1):29-37. PubMed ID: 26655680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protective role of Salmonella R mutants in Salmonella infection in mice (author's transl)].
    Schlecht S; Westphal O
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):71-88. PubMed ID: 44625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic homology among gram-negative organisms isolated from cattle with clinical mastitis.
    Tyler J; Spears H; Cullor J; Smith W; Nelson R; Martin J
    J Dairy Sci; 1991 Apr; 74(4):1235-42. PubMed ID: 1907303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray Irradiated Vaccine Confers protection against Pneumonia caused by Pseudomonas aeruginosa.
    Li Y; Wang Z; Liu X; Tang J; Peng B; Wei Y
    Sci Rep; 2016 Feb; 6():18823. PubMed ID: 26879055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The inductive immunosuppressive activity of the nonspecific lipopolysaccharide fraction of virulent Shigella sonnei].
    Borisova EV; Borisov VA
    Mikrobiol Z; 1997; 59(1):77-81. PubMed ID: 9172868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the immunological activity of a vaccine from mutant Salmonella minnesota R 595 on a model of experimental Pseudomonas aeruginosa infection in mice].
    Likhoded VG; Apollonin AV; Gremiakova TA; Artemova EK
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):103-6. PubMed ID: 6408854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.
    McCabe WR
    J Immunol; 1972 Mar; 108(3):601-10. PubMed ID: 4622185
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ
    J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.